Systemic Corticosteroid Usage in Stage 4 Pulmonary Sarcoidosis Could Offer Little Benefit, Pose Significant Health Risk

Josna Haritha, MD, MPH, completed medical school at University of Alabama at Birmingham in 2013 and finished an internal medicine residency at Virginia Commonwealth University (VCU) in 2016. She now works as a hospitalist at the McGuire VA Hospital.

Derick N. Jenkins, MD, completed medical school at Dartmouth in 2011 and finished an internal medicine residency at VCU in 2016. He now serves as a chief medical resident.

Manpreet S. Malik, MBBS, is an assistant professor in the Department of Internal Medicine at Virginia Commonwealth University School of Medicine in Richmond, Va. He completed his residency in internal medicine at UPMC, Pittsburgh and joined VCU Health in 2013 as an academic hospitalist. His areas of expertise are ultrasound-guided bedside procedures, case-based learning, faculty development and technology, and mobile apps in medicine.

References

1. Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: The British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008 Sep;63(Suppl 5):v1–v58.
2. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Eng J Med. 2007 Nov 22;357(21):2153–2165.
3. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999 Aug;160(2):736–755.
4. Shlobin OA, Nathan SD. Management of end-stage sarcoidosis: Pulmonary hypertension and lung transplantation. Eur Respir J. 2012 Jun;39(6):1520–1533.
5. Pena TA, Soubani AO, Samavati L. Aspergillus lung disease in patients with sarcoidosis: A case series and review of the literature. Lung. 2011 Apr;189(2):167–172.